| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| Pilot Study of Pancreatic Cancer Screening (NCT05058846) | University of California, San Francisco | 2022-01-20 |
| Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy (NCT05171517) | Peking Union Medical College Hospital | 2022-01-01 |
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics (NCT04905082) | City of Hope Medical Center | 2021-12-30 |
| A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up (NCT05237193) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2021-09-03 |
| Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery (NCT05830019) | Shanghai Proton and Heavy Ion Center | 2021-06-01 |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer (NCT04505553) | University of Washington | 2021-06-01 |
| The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer (NCT04602026) | Ohio State University Comprehensive Cancer Center | 2020-09-14 |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach (NCT04902144) | Fred Hutchinson Cancer Center | 2020-08-03 |
| Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer (NCT05634564) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-06-01 |
| Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction (NCT03962478) | Xuzhou Central Hospital | 2019-05-31 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer (NCT03711890) | Ohio State University Comprehensive Cancer Center | 2019-03-26 |
| Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma (NCT03785743) | Tongji Hospital | 2019-03-01 |
| Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery (NCT03745794) | M.D. Anderson Cancer Center | 2019-02-28 |
| The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer (NCT03747588) | Peking Union Medical College Hospital | 2018-12-01 |
| Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer (NCT04082455) | Shanghai Proton and Heavy Ion Center | 2018-04-01 |
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors (NCT03302403) | Kang YU | 2017-12-29 |
| Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers (NCT03267524) | City of Hope Medical Center | 2017-11-09 |
| Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer (NCT03645148) | Zhejiang Provincial People's Hospital | 2017-10-24 |
| Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer (NCT03137706) | University of Southern California | 2016-11-14 |
| First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide (NCT03164486) | Julie L. Sutcliffe, Ph.D | 2016-11-01 |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) (NCT02676349) | Institut de Cancérologie de Lorraine | 2016-10-13 |
| Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 (NCT02687230) | BioNTech Research & Development, Inc. | 2016-07-11 |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies (NCT02807844) | Novartis Pharmaceuticals | 2016-06-29 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers (NCT02683824) | Stanford University | 2016-01-12 |
| Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer (NCT02517268) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-06-24 |
| Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer (NCT03949933) | Shanghai Proton and Heavy Ion Center | 2015-05-01 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (NCT02009449) | Eli Lilly and Company | 2013-11-15 |
| Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer (NCT01774019) | Boston Scientific Corporation | 2013-02-20 |
| Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition (NCT02285660) | The Leeds Teaching Hospitals NHS Trust | 2011-06-01 |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (NCT01262040) | Memorial Sloan Kettering Cancer Center | 2010-12-14 |
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients (NCT00907166) | Cornerstone Pharmaceuticals | 2009-05-01 |
| L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN) (NCT01330823) | University Medicine Greifswald | 2006-06-01 |